These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3521671)
1. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals]. Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671 [TBL] [Abstract][Full Text] [Related]
2. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli]. Thabaut A; Meyran M; Huerre M Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217 [TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria. Shibl AM; Ishag AH; Durgham SM Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the in vitro activity of cefotetan on bacterial strains of recent hospital isolation]. Lembo M; Nani E; Covelli I; Anzivino D; Gulletta E G Batteriol Virol Immunol; 1985; 78(7-12):224-44. PubMed ID: 3870426 [TBL] [Abstract][Full Text] [Related]
5. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A; Mattina R; Cocuzza CE Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection. Webb G; Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN Int J Clin Pharmacol Res; 1987; 7(3):203-5. PubMed ID: 3298085 [TBL] [Abstract][Full Text] [Related]
7. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria]. Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617 [TBL] [Abstract][Full Text] [Related]
8. How and why aztreonam works. Rittenbury MS Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280 [TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms. Greenberg RN; Bollinger M; Compton J Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621 [TBL] [Abstract][Full Text] [Related]
11. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients]. Bartolucci M; Galluzzi F; Sanchioni G; Aureli G Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates. Giamarellou H; Sahin A; Chryssouli Z Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243 [TBL] [Abstract][Full Text] [Related]
13. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas]. Honderlick P; Gravisse J; Dardelle D; Cahen P Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768 [TBL] [Abstract][Full Text] [Related]
14. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli. Verbist L; Glupczynski Y Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections]. Salvo S; Falcidia A; Mirone L Minerva Med; 1987 Jan; 78(2):71-7. PubMed ID: 3543744 [TBL] [Abstract][Full Text] [Related]
16. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. Barry AL; Thornsberry C; Jones RN; Gavan TL Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627 [TBL] [Abstract][Full Text] [Related]
18. [Aztreonam: monocenter microbiological study with prevention experience in surgery]. Malcangi A; Pesce S; Vitale M; Martinetto P G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031 [TBL] [Abstract][Full Text] [Related]
19. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases. Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123 [TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria. Shibl AM; Ishag AH; Durgham SM J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439 [No Abstract] [Full Text] [Related] [Next] [New Search]